Skip to results
1-20 of 45
Authors: Richard Haubrich
Sort by
Journal Article
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen Open Access
Essy Mozaffari and others
Open Forum Infectious Diseases, Volume 11, Issue 6, June 2024, ofae202, https://doi.org/10.1093/ofid/ofae202
Published: 16 April 2024
Journal Article
1611. Real-World Effectiveness and Tolerability of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Treatment-Experienced People With HIV and a History of Antiretroviral Drug Resistance Mutations Open Access
Benoit Trottier and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.1446, https://doi.org/10.1093/ofid/ofad500.1446
Published: 27 November 2023
Journal Article
38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality Open Access
Essy Mozaffari and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S27–S28, https://doi.org/10.1093/ofid/ofab466.038
Published: 04 December 2021
Journal Article
536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study Open Access
François Raffi and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S369–S370, https://doi.org/10.1093/ofid/ofab466.735
Published: 04 December 2021
Journal Article
459. COVID-19 Hospitalization and 30-Day Readmission: A Cohort Study of U.S. Hospitals Open Access
Essy Mozaffari and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Page S332, https://doi.org/10.1093/ofid/ofab466.658
Published: 04 December 2021
Journal Article
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort Open Access
Essy Mozaffari and others
Clinical Infectious Diseases, Volume 75, Issue 1, 1 July 2022, Pages e450–e458, https://doi.org/10.1093/cid/ciab875
Published: 01 October 2021
Journal Article
Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States Open Access
Essy Mozaffari and others
Open Forum Infectious Diseases, Volume 9, Issue 1, January 2022, ofab498, https://doi.org/10.1093/ofid/ofab498
Published: 28 September 2021
Journal Article
Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States
Get access
Jill Blumenthal and others
Clinical Infectious Diseases, Volume 73, Issue 7, 1 October 2021, Pages 1149–1156, https://doi.org/10.1093/cid/ciab328
Published: 17 April 2021
Journal Article
Differential detection of M184V/I between plasma historical HIV genotypes and HIV proviral DNA from PBMCs Free
Nicolas Margot and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 8, August 2020, Pages 2249–2252, https://doi.org/10.1093/jac/dkaa146
Published: 15 May 2020
Journal Article
Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment Free
Amanda Mocroft and others
Clinical Infectious Diseases, Volume 70, Issue 10, 15 May 2020, Pages 2131–2140, https://doi.org/10.1093/cid/ciz601
Published: 02 July 2019
Journal Article
Analysis of drug–drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database
Get access
Nimish Patel and others
American Journal of Health-System Pharmacy, Volume 75, Issue 15, 1 August 2018, Pages 1132–1139, https://doi.org/10.2146/ajhp170613
Published: 01 August 2018
Journal Article
Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study Free
David J Moore and others
Clinical Infectious Diseases, Volume 66, Issue 10, 15 May 2018, Pages 1566–1572, https://doi.org/10.1093/cid/cix1055
Published: 24 November 2017
Journal Article
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants Open Access
Katie R Mollan and others
The Journal of Infectious Diseases, Volume 216, Issue 5, 1 September 2017, Pages 554–564, https://doi.org/10.1093/infdis/jix248
Published: 06 July 2017
Journal Article
Maraviroc, as a Switch Option, in HIV-1–infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study Free
Sarah Lilian Pett and others
Clinical Infectious Diseases, Volume 63, Issue 1, 1 July 2016, Pages 122–132, https://doi.org/10.1093/cid/ciw207
Published: 05 April 2016
Journal Article
Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy Free
Lauren E Cain and others
International Journal of Epidemiology, Volume 45, Issue 6, December 2016, Pages 2038–2049, https://doi.org/10.1093/ije/dyv295
Published: 31 December 2015
Journal Article
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols Open Access
Carrie B. Moore and others
Open Forum Infectious Diseases, Volume 2, Issue 1, Winter 2015, ofu113, https://doi.org/10.1093/ofid/ofu113
Published: 09 January 2015
Journal Article
1555Factors Associated with the Selection of Initial Antiretroviral Therapy: Real-world Channeling Open Access
Michael Saag and others
Open Forum Infectious Diseases, Volume 1, Issue suppl_1, December 2014, Page S414, https://doi.org/10.1093/ofid/ofu052.1101
Published: 01 December 2014
Journal Article
Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens
Get access
Yu Zheng and others
Clinical Infectious Diseases, Volume 59, Issue 6, 15 September 2014, Pages 888–896, https://doi.org/10.1093/cid/ciu367
Published: 19 May 2014
Journal Article
Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder
Get access
Ronald J. Ellis and others
Clinical Infectious Diseases, Volume 58, Issue 7, 1 April 2014, Pages 1015–1022, https://doi.org/10.1093/cid/cit921
Published: 18 December 2013
Journal Article
Racial Differences in Response to Antiretroviral Therapy for HIV Infection: An AIDS Clinical Trials Group (ACTG) Study Analysis
Get access
Heather J. Ribaudo and others
Clinical Infectious Diseases, Volume 57, Issue 11, 1 December 2013, Pages 1607–1617, https://doi.org/10.1093/cid/cit595
Published: 17 September 2013
Advertisement
Advertisement